Lazar Alexandra, Gelardi Fabrizia, Sagona Andrea, Rodari Marcello, Leonardi Lorenzo, Massari Roberto, D'Elia Annunziata, Soluri Andrea, Chiti Arturo, Antunovic Lidija
Vita-Salute San Raffaele University, Milan, Italy.
IRCCS San Raffaele Hospital, Milan, Italy.
Eur J Nucl Med Mol Imaging. 2025 Feb;52(3):1028-1037. doi: 10.1007/s00259-024-06970-w. Epub 2024 Nov 5.
Sentinel lymph node biopsy (SLNB) has been recognized as "the gold standard" for axillary staging in early breast cancer patients with clinically negative lymph nodes, resulting in significant morbidity decrease and quality of life improvement. This study aims to validate the performance of a newly developed handheld portable gamma camera (PGC) produced by Imagensys (Italy), in detecting and locating sentinel lymph nodes (SLNs) during the preoperative and intraoperative phases in breast cancer patients compared to conventional lymphoscintigraphy.
Adult female patients with histologically confirmed breast cancer, candidates for surgery and SLNB, were prospectively enrolled in this open-label, pre-marketing clinical trial. All patients underwent pre- operative assessment using both the PGC and conventional lymphoscintigraphy. The performance of the two devices was compared using the Poisson regression model for incidence rate ratios (IRRs). The intrinsic sensitivity of the devices was compared using the Wilcoxon Ranked Sign Test. The utility of PGC during intra-operative procedures was also evaluated. The manoeuvrability of the devices was evaluated using operator-satisfaction questioner.
Sixty-eight patients (median age 50 years, BMI 21.4) were enrolled, including two patients with bilateral breast cancer, who underwent SLNB on both axillae. The PGC demonstrated superior preoperative lymph node detection rate (IRR 8.01, 95% CI 6.11-10.50; p < 0.0001) and intrinsic device sensitivity (mean counts per second 409 ± 286 vs. 255 ± 1173 for conventional device, p = 0.0003) compared to the conventional gamma camera. Intra-operative assessment with PGC was performed in 62 patients and no additional lymph nodes were visualised. However, the conventional gamma camera demonstrated superior manoeuvrability (p < 0.0001).
The PGC handheld gamma camera showed promising results for preoperative SLN assessment in patients with breast cancer. The limited manoeuvrability may be related to the operator's experience leading to higher inter-operator variability. Appropriate training and frequent use of nuclear medicine and surgical equipment could overcome this limitation.
前哨淋巴结活检(SLNB)已被公认为临床腋窝淋巴结阴性的早期乳腺癌患者腋窝分期的“金标准”,可显著降低发病率并提高生活质量。本研究旨在验证意大利Imagensys公司新开发的手持式便携式γ相机(PGC)在乳腺癌患者术前和术中检测及定位前哨淋巴结(SLN)方面的性能,并与传统淋巴闪烁显像进行比较。
本开放标签、上市前临床试验前瞻性纳入了组织学确诊为乳腺癌、拟行手术及SLNB的成年女性患者。所有患者术前均使用PGC和传统淋巴闪烁显像进行评估。使用泊松回归模型比较两种设备的发病率比(IRR)以评估其性能。使用Wilcoxon秩和检验比较设备的固有灵敏度。还评估了PGC在术中操作的实用性。使用操作者满意度问卷评估设备的可操作性。
共纳入68例患者(中位年龄50岁,BMI 21.4),其中2例双侧乳腺癌患者双侧腋窝均接受了SLNB。与传统γ相机相比,PGC术前淋巴结检测率更高(IRR 8.01,95%CI 6.11 - 10.50;p < 0.0001),且设备固有灵敏度更高(传统设备每秒平均计数为255 ± 1173,PGC为409 ± 286,p = 0.00)。62例患者术中使用PGC进行评估,未发现额外淋巴结。然而,传统γ相机的可操作性更佳(p < 0.0001)。
PGC手持式γ相机在乳腺癌患者术前SLN评估中显示出良好的效果。其可操作性有限可能与操作者经验有关,导致操作者间变异性较高。适当的培训以及核医学和手术设备的频繁使用可克服这一局限性。